Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience.
about
MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysisAdrenal tumors with unexpected outcome: a review of the literatureAdrenal masses: A urological perspectiveAdrenal incidentaloma: A puzzle for clinicianApproach to the patient with an adrenal incidentaloma.Primary aldosteronism of late onset: a case report.Preoperative workup in the assessment of adrenal incidentalomas: outcome from 282 consecutive laparoscopic adrenalectomiesPrevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus.Clinical utility of quantitative imaging.Bilateral primary adrenal non-Hodgkin's lymphoma without adrenal insufficiency.Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumorsAdrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancerBilateral Adrenal Incidentalomas: A Rare Presentation of Lung Cancer.Analysis of BCLI, N363S and ER22/23EK Polymorphisms of the Glucocorticoid Receptor Gene in Adrenal Incidentalomas.Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art.Radiographic Characteristics of Adrenal Masses in Oncologic PatientsLikelihood ratio of computed tomography characteristics for diagnosis of malignancy in adrenal incidentaloma: systematic review and meta-analysis.Is Preoperative Biochemical Testing for Pheochromocytoma Necessary for All Adrenal Incidentalomas?Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.A Case of Oncocytic Adrenocortical Neoplasm of Borderline (Uncertain) Malignant Potential.Clinical characteristics and follow-up of Korean patients with adrenal incidentalomasCT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies.The clinical significance of adrenal incidentalomas.Adrenocortical carcinoma: a clinician's update.Pheochromocytoma with Synchronous Ipsilateral Adrenal Cortical Adenoma.Management of Adrenal Masses.Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy.Adrenocortical tumours: high CT attenuation value correlates with eosinophilia but does not discriminate lipid-poor adenomas from malignancy.Diagnostic performance of unenhanced computed tomography and 18 F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours.Adrenocortical oncocytoma presenting as Cushing's syndrome: an additional report of a paediatric case.Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.Biochemical and radiological relationships in patients with pheochromocytoma: lessons from a case control study.High prevalence of autonomous aldosterone secretion among patients with essential hypertension.
P2860
Q26743458-A4154E48-B6B7-4EA8-95B6-077FB1CE6AB9Q26852791-D684C5C7-F49F-46E8-B082-E8AAD9D7104FQ28072224-62805AD9-9550-42FC-832D-A6791C372109Q33357125-FE8ACF96-2E55-4645-9EF9-2F01489567E6Q34113205-8D600107-B91D-4832-9DA8-9DC1BE1AB402Q34361496-EA6F4F60-0368-44F6-9F50-48BFE431CC6CQ34463730-5EA355BC-8A84-4718-93CE-D6AAD80D1D3EQ34478141-5FACCFF4-D016-4E11-96EB-325D25EDD821Q34656915-0C416260-C321-4D16-83E4-CBEDF6E029A2Q35218389-50CF9978-05B4-41D7-944F-B4F085F99EEFQ35396089-6D6D7157-9613-4CBF-AB3D-0A7C27E8F77BQ35597963-0FDA5784-0A73-4AF7-B4DE-D2FC07360E3DQ35619919-4CB72ACB-6D41-4D4D-B87C-DCE11A7E0436Q35697620-FF0E8430-CB90-4E1E-AB4B-4AE775AC4C9DQ36138264-05520520-3F7C-4AFB-A077-150B6DFDFD79Q36355661-0265ABF0-4CC2-400B-864A-5E36E3403C43Q36717010-74A85F48-6151-4112-9BE0-0A15671E692AQ36820349-83997728-04EA-4134-AF99-36D6E76F00ABQ37016655-E543CED4-AB0A-48C3-BBE7-A077A7D7795DQ37062950-00613EF2-46EA-41C0-8A1B-4B46987035EDQ37095547-B2685594-E9B5-45FE-87F6-C83980D6818DQ37138746-72ED2E41-5E9A-46D3-AB12-3926D669EACBQ37470035-E527C6DD-DAAD-49D9-8B2B-6681D3FCC4A0Q37826439-316AEF18-4565-4698-BB8E-C2E42FF659E4Q37850996-BB5D5C7E-F463-4580-A90D-1CFAA5DFD1DDQ38650021-8C522DD4-7B6A-4200-BA00-5DFABEB8F135Q39105776-22C8A72C-5B8D-4B19-9ABA-189819C487E0Q41472378-0180DFFC-285A-4894-A5B9-D3D5D42BA7AFQ45211243-39F39384-CE73-4CD4-A7CC-BA573BFB305EQ47795306-69C85331-BB7D-4B32-983B-EA9A2BE07F81Q51063061-26095754-BCE9-4169-A6D7-0AEF9B28AAA4Q51668273-A24C4C89-0D57-4328-AAD7-657C2106E253Q53080771-D9C2DCE0-0979-4DA6-8B10-5C4D6872CFB1Q53227686-5E5C075F-F315-4D42-9D45-E445D5DFCEF7
P2860
Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Clinical utility of noncontras ...... : Cleveland Clinic experience.
@en
Clinical utility of noncontrast computed tomography attenuation value
@nl
type
label
Clinical utility of noncontras ...... : Cleveland Clinic experience.
@en
Clinical utility of noncontrast computed tomography attenuation value
@nl
prefLabel
Clinical utility of noncontras ...... : Cleveland Clinic experience.
@en
Clinical utility of noncontrast computed tomography attenuation value
@nl
P2093
P356
P1476
Clinical utility of noncontras ...... s: Cleveland Clinic experience
@en
P2093
Adriana G Ioachimescu
Allan Siperstein
Amir H Hamrahian
Emmanuel L Bravo
Gaspar Motta-Ramirez
Hari Bogabathina
Howard S Levin
Inderbir S Gill
Sethu Reddy
P304
P356
10.1210/JC.2004-1627
P407
P577
2004-11-30T00:00:00Z